Curran Terrieinsider trades
In SEC Form 4 filings, Curran Terrie is listed as Director of Arcutis Biotherapeutics, Inc. (ARQT). In the last 90 days, Curran Terrie sold $984K of Arcutis Biotherapeutics, Inc. (ARQT) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | Director | 9 | Aug 28 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | Aug 27 | Aug 28 | M | 11,148 | $7.51 | $83,721 | 34,674 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 27 | Aug 28 | S | 11,148 | $25.03 | Sale −$279,028 | 23,526 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 27 | Aug 28 | M | 27,052 | $8.63 | $233,459 | 50,578 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 27 | Aug 28 | S | 27,052 | $25.03 | Sale −$677,095 | 23,526 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 27 | Aug 28 | M · derivative | 11,148 | $7.51 | $83,721 | not reported | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 27 | Aug 28 | M · derivative | 27,052 | $8.63 | $233,459 | not reported | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 20 | Aug 24 | M | 1,072 | $7.51 | $8,051 | 24,598 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 20 | Aug 24 | S | 1,072 | $26.04 | Sale −$27,912 | 23,526 | No | Form 4 |
| ARQTArcutis Biotherapeutics, Inc. | Aug 20 | Aug 24 | M · derivative | 1,072 | $7.51 | $8,051 | 11,148 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.